White & Case LLP has advised ICON plc. Latham & Watkins LLP has advised the initial purchasers. ICON plc, a world-leading clinical research organization headquartered in...
ICON Completes US$2.15 Billion Senior Unsecured Notes Offering
Tarsus Pharmaceuticals Signs Agreement to Acquire Alkeus Pharmaceuticals
Gunderson Dettmer has advised Tarsus Pharmaceuticals. Latham & Watkins has advised Alkeus Pharmaceuticals. Tarsus Pharmaceuticals (Nasdaq: TARS) has entered into a definitive agreement to acquire Alkeus...
Scribe Therapeutics Completes $155.51 Million Initial Public Offering and Private Placement
Fenwick has advised Scribe Therapeutics. Latham & Watkins has advised the underwriters. Scribe Therapeutics Inc., a clinical-stage biotechnology company specializing in in vivo CRISPR technologies, has...
Eli Lilly Acquires AtaiBeckley to Expand Mental Health Treatment Pipeline in $3.8 Billion Deal
Ropes & Gray has advised Eli Lilly and Company. Latham & Watkins has advised AtaiBeckley Inc. Eli Lilly and Company (NYSE: LLY) has entered into a...
Remix Therapeutics and Passage Bio Announce Merger and $100 Million Private Placement
Latham & Watkins LLP has advised Remix Therapeutics. Fenwick & West LLP has advised Passage Bio. Cooley LLP has advised Goldman Sachs & Co. LLC, Jefferies...
Serapha Bio and Boundless Bio Announce Merger and $230 Million Private Placement
Gibson Dunn has advised Serapha Bio, Inc. Latham & Watkins has advised Boundless Bio, Inc. Serapha Bio, Inc., a privately held biotechnology company, and Boundless Bio,...
Mobia Medical Raises $150 Million in Initial Public Offering
Latham & Watkins LLP has advised Mobia Medical, Inc. Cleary Gottlieb has represented the underwriters. Mobia Medical, Inc., a commercial-stage medical device company, completed its initial...
Paratek Pharmaceuticals Completes Combination with Radius Health and Secures $1.3 Billion Financing
Skadden has advised B-FLEXION Life Sciences and Paratek Pharmaceuticals. Mintz has advised Sixth Street. Latham & Watkins has advised Blackstone Credit & Insurance. Paratek Pharmaceuticals, Inc.,...
Vaxcyte Completes $632.5 Million Public Offering of Common Stock
Skadden has advised Vaxcyte, Inc. Latham & Watkins LLP has advised the underwriters. Vaxcyte, Inc. has completed the closing of an underwritten public offering of 12,650,000...
Vir Biotechnology Completes $172.5 Million Public Offering of Common Stock
Gunderson Dettmer, with support from Ropes & Gray LLP, Sheppard, Mullin, Richter & Hampton LLP, and Fox Rothschild LLP, has advised Vir Biotechnology. Latham & Watkins...
Satellos Bioscience Completes US$57.2 Million Cross-Border Public Offering and Nasdaq Listing
Mintz has advised Satellos Bioscience Inc. Latham & Watkins has represented the underwriters. Satellos Bioscience Inc., a clinical-stage biotechnology company, has completed a US$57.2 million underwritten...
Corvus Pharmaceuticals Completes US$201 Million Upsized Public Offering
Latham & Watkins LLP has advised Corvus Pharmaceuticals. Paul Hastings LLP has advised Jefferies and Goldman Sachs & Co. LLC. Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS) has...